Michael Lutz
Chief Executive Officer at Iota Sciences Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Alexander Feuerborn | M | - |
Iota Sciences Ltd.
Iota Sciences Ltd. Packaged SoftwareTechnology Services Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom. | 8 years |
Edmond Walsh | M | - |
Iota Sciences Ltd.
Iota Sciences Ltd. Packaged SoftwareTechnology Services Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom. | 8 years |
Nils Aage Brünner | M | 72 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 4 years |
Gianluca Maroncelli | M | - |
NTP Nano Tech Projects SRL
NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services NTP Nano Tech Projects SRL develops Nano-Eye, an advanced optical-laser microscopy device that can achieve optical resolutions below the micron size. The company was founded by Adolfo Carloni, Gianluca Maroncelli and Massimo Galavotti in 2012 and is headquartered in Sant'Angelo in Vado, Italy. | 12 years |
Michael Schaefer | M | - |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 2 years |
Kenneth Graabek Johansen | M | 48 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 3 years |
Ole Thastrup | M | 71 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 18 years |
Grith Hagel | F | 65 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 18 years |
Peter Cook | M | - |
Iota Sciences Ltd.
Iota Sciences Ltd. Packaged SoftwareTechnology Services Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom. | 8 years |
Fernando Andreu | M | 60 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 3 years |
Adolfo Carloni | M | - |
NTP Nano Tech Projects SRL
NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services NTP Nano Tech Projects SRL develops Nano-Eye, an advanced optical-laser microscopy device that can achieve optical resolutions below the micron size. The company was founded by Adolfo Carloni, Gianluca Maroncelli and Massimo Galavotti in 2012 and is headquartered in Sant'Angelo in Vado, Italy. | 12 years |
Stevens Philip | M | - |
Noscendo GmbH
Noscendo GmbH Medical SpecialtiesHealth Technology Noscendo GmbH is a diagnostics company, which engages in the identification and assessment of bloodstream-associated pathogens and other infections. It offers logistics, sample preparation, sequencing, data analysis, and reports. The company was founded by Philip Stevens, Silke Grumaz and Kai Sohn and is headquartered in Duisburg, Germany. | - |
Massimo Galavotti | M | - |
NTP Nano Tech Projects SRL
NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services NTP Nano Tech Projects SRL develops Nano-Eye, an advanced optical-laser microscopy device that can achieve optical resolutions below the micron size. The company was founded by Adolfo Carloni, Gianluca Maroncelli and Massimo Galavotti in 2012 and is headquartered in Sant'Angelo in Vado, Italy. | 12 years |
Jesper Kristiansen | M | 59 | 3 years | |
Manuel Fernández | M | - | 2 years | |
Mark Gray | M | 54 | 2 years | |
Nick Dixon Clegg | M | - |
Iota Sciences Ltd.
Iota Sciences Ltd. Packaged SoftwareTechnology Services Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom. | 4 years |
Raphael Gruber | M | 60 | 2 years | |
Trevor Hawkins | M | - |
Noscendo GmbH
Noscendo GmbH Medical SpecialtiesHealth Technology Noscendo GmbH is a diagnostics company, which engages in the identification and assessment of bloodstream-associated pathogens and other infections. It offers logistics, sample preparation, sequencing, data analysis, and reports. The company was founded by Philip Stevens, Silke Grumaz and Kai Sohn and is headquartered in Duisburg, Germany. | 5 years |
Trevor Nicholls | M | 67 |
Iota Sciences Ltd.
Iota Sciences Ltd. Packaged SoftwareTechnology Services Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom. | - |
Lilly Bella Paloma Circe Bussmann | M | 33 |
Iota Sciences Ltd.
Iota Sciences Ltd. Packaged SoftwareTechnology Services Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom. | - |
Stephen D. Allen | M | 65 |
NTP Nano Tech Projects SRL
NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services NTP Nano Tech Projects SRL develops Nano-Eye, an advanced optical-laser microscopy device that can achieve optical resolutions below the micron size. The company was founded by Adolfo Carloni, Gianluca Maroncelli and Massimo Galavotti in 2012 and is headquartered in Sant'Angelo in Vado, Italy. | 1 years |
Camilla Huse Bondesson | M | 66 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 5 years |
Povl-André Bang Bendz | M | 62 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 10 years |
Ulrich Karl Walter Spengler | M | 57 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 11 years |
Simon Hesse Hoffmann | M | 46 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 7 years |
Laura Iris Ferro | M | 72 |
NTP Nano Tech Projects SRL
NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services NTP Nano Tech Projects SRL develops Nano-Eye, an advanced optical-laser microscopy device that can achieve optical resolutions below the micron size. The company was founded by Adolfo Carloni, Gianluca Maroncelli and Massimo Galavotti in 2012 and is headquartered in Sant'Angelo in Vado, Italy. | 1 years |
Jørgen Drejer | M | 69 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 7 years |
Rino Malaponti | M | - |
NTP Nano Tech Projects SRL
NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services NTP Nano Tech Projects SRL develops Nano-Eye, an advanced optical-laser microscopy device that can achieve optical resolutions below the micron size. The company was founded by Adolfo Carloni, Gianluca Maroncelli and Massimo Galavotti in 2012 and is headquartered in Sant'Angelo in Vado, Italy. | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michel Klimkeit | M | - | 1 years | |
Maarten van der Linden | M | 55 | 4 years | |
Carit Jacques Andersen | M | 60 | 2 years | |
Henrik Harling | M | 71 | 3 years | |
Pia van der Zee | F | - | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
Sweden | 13 | 38.24% |
Denmark | 11 | 32.35% |
Italy | 6 | 17.65% |
United Kingdom | 6 | 17.65% |
Germany | 2 | 5.88% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Lutz
- Personal Network